Factores asociados a la adherencia a la vacunación frente a la COVID-19 en adultos jóvenes: revisión sistemática.
e202510057
Palabras clave:
Infecciones por coronavirus, Vacuna COVID-19, Cumplimiento y adherencia al tratamiento, Desconfianza ante la vacunaciónResumen
FUNDAMENTOS // Los adultos jóvenes pueden tener más probabilidades de propagar la COVID-19, ya que muestran un bajo cumplimiento de las directrices de Salud Pública y son más reacios a vacunarse. El propósito de esta revisión fue disponer de la evidencia más actual en relación con la evaluación sobre la adherencia a la vacunación frente a la COVID-19 en adultos jóvenes.
MÉTODOS // La busqueda bibliográfica se realizó en bases de datos Cumulative Index to Nursing and Allied Health Literature (CINAHL), SCOPUS, Scielo, MedLine/PubMed, Cochrane y en el buscador Google Scholar, con lenguaje libre y controlado, utilizando los términos de búsqueda MeSh: “Treatment Adherence and Compliance”, “COVID-19 Vaccines”, “Young Adult”. Se analizaron diez artículos seleccionados. Los artículos fueron seleccionados en función de su relevancia, que estuvieran publicados en revistas académicas revisadas por pares y entre 2021 y 2024.
RESULTADOS // La herramienta principal de estudio representa la adherencia de las vacunas contra la COVID-19. Los temas de discusión más importantes extraídos en los artículos analizados hacen referencia a la preocupación ante los efectos secundarios, la desconfianza, las creencias o el nivel de ingresos bajos.
CONCLUSIONES // Los hallazgos de este estudio indican la necesidad de realizar programas de promoción de vacunación para brindar información accesible, transparente y apropiada para la edad. De este modo, podría ser considerada una herramienta útil para mejorar la adherencia y confianza hacia la vacuna contra la COVID-19.
Descargas
Citas
World Health Organization. WHO health emergency dashboard. 2020. [Acceso 25/03/2024]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Tran VD, Pak TV, Gribkova EI, Galkina GA, Loskutova EE, Dorofeeva V et al. Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia. Pharm Pract (Granada). 2021;19:2276. DOI: https://doi.org/10.18549/PharmPract.2021.1.2276
WHO. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020 [acceso 25/03/2024]. Disponible en: https://www.who.int/director-general/speeches/detail/whodirector- general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
Our World in Data. Coronavirus pandemic (COVID-19); 2022 Feb 22 [acceso 25/03/2024]. Disponible en: https://ourworldindata.org/coronavirus
Bergman J, Ballin M, Nordstrom A, Nordstrom P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36(3):287-298. DOI: https://doi.org/10.1007/s10654-021-00732
Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2vaccines: A systematic reviewandmeta-analysis. JMedVirol2021;93(12):6486-6495. DOI: https://doi.org/10.1002/jmv.27203
Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021;385(19):1761-1773. DOI: https://doi.org/10.1056/ NEJMoa2110345
Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. ProcNatlAcadSci2021;118(10). DOI: https://doi.org/10.1073/pnas.2021726118 e2021726118
Afifi TO, Salmon S, Taillieu T, Stewart-Tufescu A, Fortier J, Driedger SM. Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies. Vaccine. 2021 Jun 11;39(26):3473-3479. DOI: https://doi.org/10.1016/j.vaccine.2021.05.026
MacDonald NE. Vaccine hesitancy: Definition, scope and determinant Vaccine. 2015;33:4161-4164. DOI: https://doi.org/10.1016/j.vaccine.2015.04.036
World Health Organization. Ten threats to global health in 2019. 2019 [acceso 25/03/2024]. Disponible en: https://www.who.int/newsroom/spotlight/ten-threats-to-global-health-in-2019
Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27;33 Suppl4:D66-71. DOI: https://doi.org/10.1016/j.vaccine.2015.09.035
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021 Feb;1:100012. DOI: https://doi.org/ 10.1016/j.lanepe.2020.100012
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, RabinK et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med2021;27 (2):225-228. DOI: https://doi.org/10.1038/s41591-020-1124-9
Andrews JL, Foulkes L, Blakemore SJ. Peer Influence in Adolescence: Public-Health Implications for COVID-19. Trends Cogn Sci. 2020 Aug;24(8):585-587. DOI: https://doi.org/10.1016/j.tics.2020.05.001
Nivette A, Ribeaud D, Murray A, Steinhoff A, Bechtiger L, Hepp U et al. Non-compliance with COVID-19-related public health measures among young adults in Switzerland: Insights from a longitudinal cohort study. Soc Sci Med. 2021 Jan;268:113370. DOI: https://doi.org/10.1016/j.socscimed.2020.113370
Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2022 Oct;52(14):3127-3141. DOI: https://doi.org/10.1017/S0033291720005188
Adams SH, Schaub JP, Nagata JM, Park MJ, Brindis CD, Irwin CE. Young Adult Perspectives on COVID-19 Vaccinations. J Adol Health. 2021;69(3):511-514. DOI: https://doi.org/10.1016/j.jadohealth.2021.06.003
Brandt EJ, Rosenberg J, Waselewski ME, Amaro X, Wasag J, Chang T. National Study of Youth Opinions on Vaccination for COVID-19 in the US. JAdolesc Health 2021;68(5):869-872. DOI: https://doi.org/10.1016/j.jadohealth.2021.02.013
Zhu P, Tatar O, Griffin-Mathieu G, Perez S, Haward B, Zimet G et al. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial. JMIR Public Health Surveill. 2022 May 30;8(5):e37328. DOI: https://doi.org/10.2196/37328
Walsh JC, Comar M, Folan J, Williams S, Kola-Palmer S. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK. Acta Psychol (Amst). 2022 May;225:103550. DOI: https://doi.org/10.1016/j.actpsy.2022.103550
Urrútia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis [PRISMA declaration: a proposaltoimprovethepublicationofsystematicreviews and meta-analyses]. Med Clin (Barc). 2010;135(11):507-511. DOI: https://doi.org/10.1016/j.medcli.2010.01.015
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467-473. DOI: https://doi.org/10.7326/M18-0850
Higgins JP, Altman DG, Gotzsche PC et al. Herramienta para evaluar el riesgo de sesgo en los ensayos aleatorios. BMJ. 2011 [consultado 25 de marzo 2024]. Disponible en: https://es.cochrane.org/sites/es.cochrane.org/files/uploads/Manual_Cochrane_510_reduit.pdf
Kim S, Willis E, Wehlage S, Scheffer-Wentz H, Dulitz M. COVID-19 vaccine hesitancy and short-term and long-term intentions among unvaccinated young adults: a mixed-method approach. BMC Public Health. 2022 Nov 7;22(1):2030. DOI: https://doi.org/10.1186/s12889-022-14448-3
Hossain MS, Islam MS, Pardhan S, Banik R, Ahmed A, Islam MZ et al. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study. PLoS One. 2022 Aug 23;17(8):e0269944. DOI: https://doi.org/ 10.1371/journal.pone.0269944
Noh Y, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J et al. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey. Epidemiol Health. 2022;44:e2022061. DOI: https://doi.org/10.4178/epih.e2022061
Dai H, Barrington-Trimis JL, Unger JB, Baezconde-Garbanati L, Leventhal AM. Patterns and mediators of racial and ethnic disparities in COVID-19 vaccine hesitancy among young adults. Prev Med. 2022 Jun;159:107077. DOI: https://doi.org/10.1016/j.ypmed.2022.107077
Moscardino U, Musso P, Inguglia C, Ceccon C, Miconi D, Rousseau C. Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy. Vaccine. 2022 Apr 6;40(16):2379-2387. DOI: https://doi.org/10.1016/j.vaccine.2022.03.018
Moccia G, Carpinelli L, Savarese G, De Caro F. Vaccine Hesitancy and the Green Digital Pass: A Study on Adherence to the Italian COVID-19 Vaccination Campaign. Int J Environ Res Public Health. 2022 Mar 3;19(5):2970. DOI: https://doi.org/10.3390/ijerph19052970
Zhang P, Li Y, Wang H, Luo L, Wang P, Wang H et al. COVID-19 Vaccine Hesitancy Among Older Adolescents and Young Adults: A National Cross-Sectional Study in China. Front Public Health. 2022 May 12;10:877668. DOI: https://doi.org/10.3389/fpubh.2022.877668
Su Y, Li S, Huang F, Xue J, Zhu T. Exploring the Influencing Factors of COVID-19 Vaccination Willingness among Young Adults in China. Int J Environ Res Public Health. 2023 Feb 23;20(5):3960. DOI: https://doi.org/10.3390/ijerph20053960
Yang F, Li X, Su X, Xiao T, Wang Y, Hu P et al. A study on willingness and influencing factors to receive COVID-19 vaccination among Qingdao residents. Hum Vaccin Immunother. 2021 Feb 1;17(2):408-413. DOI: https://doi.org/10.1080/21645515.2020.1817712
El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLoS One. 2021 Apr 23;16(4):e0250555. DOI: https://doi.org/10.1371/journal.pone.0250555
Zarbo C, Candini V, Ferrari C, d’Addazio M, Calamandrei G, Starace F et al. COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination. Front Public Health. 2022 Apr 29;10:873098. DOI: https://doi.org/10.3389/fpubh.2022.873098
Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T et al. Trends in COVID-19 vaccination intent from pre- to post-COVID-19 vaccine distribution and their associations with the 5C psychological antecedents of vaccination by sex and age in Japan. Hum VaccinImmunother. 2021 Nov 2;17(11):3954-3962. DOI: https://doi.org/10.1080/21645515.2021.1968217
Qiao S, Friedman DB, Tam CC, Zeng C, Li X. Vaccine acceptance among college students in South Carolina: Do information sources and trust in information make a difference? medRxiv: the preprint server for health sciences. 2020. DOI: https://doi.org/10.1101/2020.12.02.20242982
Cellule d’Analyseen Sciences Sociales (CASS). Humanitarian Programme Recommendations for COVID-19 Based on Social Sciences Evidence from the DRC Ebola Outbreak Response. 2020 [acceso 25/03/2024]. Disponible en: https://www.socialscienceinaction.org/resources/humanitarian-programmerecommendations-covid-19-based-social-sciences-evidence-drc-ebola-outbreak-response/
Schwartz JL. Evaluating and Deploying Covid-19 Vaccines-The Importance of Transparency, Scientific Integrity, and Public Trust. N Engl J Med. 2020; 383: 1703–1705. DOI: https://doi.org/10.1056/ NEJMp2026393
Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2020; 43: 445-449. DOI: https://doi.org/10.1093/pubmed/fdaa230
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021 Feb;1:100012. DOI: https://doi.org/10.1016/j.lanepe.2020.100012
Sønderskov KM, Vistisen HT, Dinesen PT, Østergaard SD. COVID-19 booster vaccine willingness. Dan Med J 2021;69:A10210765
Truong J, Bakshi S, Wasim A, Ahmad M, Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2022 Feb 17;37(1):daab105. DOI: https://doi.org/10.1093/heapro/daab105
Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021 Oct;40:101113. DOI: https://doi.org/10.1016/j.eclinm.2021.101113
Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021 Mar;272:113638. DOI: https://doi.org/10.1016/j.socscimed.2020.113638
Gold JAW, Rossen LM, Ahmad FB, Sutton P, Li Z, Salvatore PP et al. Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1517-1521. DOI: https://doi.org/10.15585/mmwr.mm6942e1
The Centers for Disease Control and Prevention, 2021a. CDC COVID Data Tracker: Demographic Trends of COVID-19 Cases and Deaths in the US Reported to CDC. [Acceso 25/03/2024]. Disponible en: https://stacks.cdc.gov/view/cdc/99332
Lopez L 3rd, Hart LH 3rd, Katz MH. Racial and Ethnic Health Disparities Related to COVID-19. JAMA. 2021 Feb 23;325(8):719-720. DOI: https://doi.org/10.1001/jama.2020.26443
Robinson E, Jones A, Lesser I, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative esamples. Vaccine2021;39 (15):2024-2034. DOI: https://doi.org/10.1016/j.vaccine.2021.02.005
Brandt EJ, Rosenberg J , Waselewski ME, Amaro X, Wasag J, Chang T. National Study of Youth Opinions on Vaccination for COVID-19 in the US. J Adolesc Health 2021;68(5):86-872. DOI: https://doi.org/10.1016/j.jadohealth.2021.02.013
Rozek LS, Jones P, Menon A, Hicken A, Apsley S, King EJ. Understanding Vaccine Hesitancy in the Context of COVID-19: The Role of Trust and Confidence in a Seventeen-Country Survey. Int J Public Health. 2021 May 14;66:636255. DOI: https://doi.org/10.3389/ijph.2021.636255
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. (2020) 396:479-488. DOI: https://doi.org/10.1016/S0140-6736(20)31605-6
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. (2020) 383:2603-2615. DOI: https://doi.org/10.1056/NEJMoa2034577
Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” - A Systematic Review. Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623. DOI: https://doi.org/10.2147/RMHP.S311074
Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(7). DOI: https://doi.org/10.3201/eid2607.200282
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. E Clinical Medicine. 2020; 26:100495. DOI: https://doi.org/10.1016/j.eclinm.2020
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020:1-4. DOI: https://doi.org/10.1038/s41591-020-1124-9
Descargas
Archivos adicionales
Publicado
Versiones
- 07-10-2025 (3)
- 07-10-2025 (2)
- 02-10-2025 (1)
Cómo citar
Licencia
Derechos de autor 2025 Francisco Miguel Escandell Rico, Lucía Pérez Fernández
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
![¿Cómo evaluar para la RESP? [PARA REVISORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-revisores-0eaa113abcbc4fc554c7c6c7840ca4c6.jpg)
![¿Cómo recibir avisos sobre nuevos artículos de la RESP? [PARA LECTORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-lectores-aa689338e95aab07df45b4b0d583188f.jpg)
